Childhood Immunization and Public Health
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 21
Special Issue Editor
Interests: consultant pediatrician; neonatologist; pediatric gastroenterologist; global vaccination coverage; vaccine hesitancy; vaccine equity; mandatory vs. voluntary vaccination policies
Special Issue Information
Dear Colleagues,
Vaccination programs have been incredibly successful in improving child survival and health globally over the past few decades. However, due to the SARS-CoV-2 pandemic, vaccination coverage has significantly decreased, and the recovery process has been slow. Each year, around 20 million infants do not receive complete protection against vaccine-preventable infections, with many falling into the group that has not received any vaccines.
We invite you to contribute your research to help advance our understanding of global public child health. Your contributions should focus on factors that either facilitate or hinder vaccine uptake in different settings and strategies to address obstacles such as vaccine hesitancy and inequity. This Special Issue aims to take a multidisciplinary approach to generate new ideas for improving childhood immunization coverage, benefiting individual and public health.
We welcome original research articles, reviews, and commentaries for this Special Issue. Research areas include laboratory and clinical vaccine research, utilization, and immunization research. We look forward to receiving your contributions.
Dr. Carsten Krüger
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- compulsory/mandatory vaccination
- coverage
- local vaccination culture
- pandemics
- trust
- vaccination frameworks
- vaccine equity
- vaccine hesitancy
- zero-dose
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
